Aegis Capital Initiates Coverage On Varian Medical Systems to Hold

Aegis Capital Initiates Coverage On Varian Medical Systems(VAR). The shares have been rated Hold. The rating by Aegis Capital was issued on Feb 6, 2017.

In a different note, On Jan 26, 2017, Evercore ISI Group said it Downgrades its rating on Varian Medical Systems. The shares have been rated ‘Sell’ by the firm.

Varian Medical Systems (VAR) made into the market gainers list on Tuesdays trading session with the shares advancing 0.22% or 0.17 points. Due to strong positive momentum, the stock ended at $78.43, which is also near the day’s high of $79.01. The stock began the session at $78.38 and the volume stood at 8,22,272 shares. The 52-week high of the shares is $94.482729 and the 52 week low is $64.803843. The company has a current market capitalization of $7,329 M and it has 9,34,50,388 shares in outstanding.

Varian Medical Systems(VAR) last announced its earnings results on Jan 25, 2017 for Fiscal Year 2017 and Q1.Company reported revenue of $763.300M. Analysts had an estimated revenue of $766.990M. Earnings per share were $1.09. Analysts had estimated an EPS of $1.05.

Several Insider Transactions has been reported to the SEC. On Jan 6, 2017, Dow R Wilson (President and CEO) sold 13,334 shares at $88.74 per share price.Also, On Dec 8, 2016, John W Kuo (SVP, Gen Counsel and Secretary) sold 1,267 shares at $90.33 per share price.On Nov 1, 2016, Timothy E Guertin (director) sold 4,000 shares at $90.05 per share price, according to the Form-4 filing with the securities and exchange commission.

Varian Medical Systems Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy radiosurgery proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical scientific and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection. The Company offers tools for fighting cancer taking X-ray images and protecting ports and borders. The Company’s products include linear accelerators brachytherapy afterloaders treatment simulation and verification equipment accessories information management treatment planning and image processing software. The Company’s customers include university research and community hospitals private and governmental institutions healthcare agencies doctors’ offices and cancer care clinics.

Share this post

Leave a Reply